A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

ABSTRACT: This phase IIA trial investigates the side effects of Ad5.F35-hGCC-PADRE vaccine and to see how well it works in treating patients with gastrointestinal adenocarcinoma. Ad5.F35-hGCC-PADRE vaccine may help to train the patient’s own immune system to identify and kill tumor cells and prevent it from coming back.

DISEASE(S): Adenocarcinoma,Stage Iva Colorectal Cancer Ajcc V8,Colorectal Adenocarcinoma,Gastrointestinal Neoplasms,Gastric Adenocarcinoma,Stage Iib Pancreatic Cancer Ajcc V8,Clinical Stage Ii Gastric Cancer Ajcc V8,Pathologic Stage Iib Gastric Cancer Ajcc V8,Pathologic Stage Iii Gastric Cancer Ajcc V8,Pathologic Stage Iii Esophageal Adenocarcinoma Ajcc V8,Stage Iiic Colorectal Cancer Ajcc V8,Neoplasms,Pancreatic Ductal Adenocarcinoma,Stage Ivb Colorectal Cancer Ajcc V8,Pathologic Stage Iib Esophageal Adenocarcinoma Ajcc V8,Pathologic Stage Iiia Esophageal Adenocarcinoma Ajcc V8,Esophageal Neoplasms,Stage Iii Pancreatic Cancer Ajcc V8,Small Intestinal Adenocarcinoma,Stage Iia Pancreatic Cancer Ajcc V8,Colorectal Neoplasms,Malignant Solid Neoplasm,Clinical Stage Iii Gastric Cancer Ajcc V8,Stage Ia Pancreatic Cancer Ajcc V8,Pancreatic Neoplasms,Stomach Neoplasms,Pathologic Stage Iiia Gastric Cancer Ajcc V8,Clinical Stage Iia Gastric Cancer Ajcc V8,Digestive System Neoplasms,Stage Iiib Colorectal Cancer Ajcc V8,Pathologic Stage Iiic Gastric Cancer Ajcc V8,Stage Iv Colorectal Cancer Ajcc V8,Stage Ib Pancreatic Cancer Ajcc V8,Malignant Digestive System Neoplasm,Clinical Stage Iii Esophageal Adenocarcinoma Ajcc V8,Stage Iiia Colorectal Cancer Ajcc V8,Stage I Pancreatic Cancer Ajcc V8,Clinical Stage Iib Esophageal Adenocarcinoma Ajcc V8,Stage Ii Pancreatic Cancer Ajcc V8,Pathologic Stage Ii Gastric Cancer Ajcc V8,Clinical Stage Iib Gastric Cancer Ajcc V8,Stage Iiia Small Intestinal Adenocarcinoma Ajcc V8,Stage Iii Colorectal Cancer Ajcc V8,Stage Iii Small Intestinal Adenocarcinoma Ajcc V8,Pathologic Stage Iiib Gastric Cancer Ajcc V8,Pathologic Stage Iiib Esophageal Adenocarcinoma Ajcc V8

PROVIDER: 2317938 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR